SMARCA4 and neoplasm: Of the mutations found in the WT (∼69) and Brg1-KO (∼63) tumor cells, we determined that 56/69 (∼80%) and 47/63 (∼75%) Trp53 mutations occurred between amino acids 100-300, which is the DNA binding domain (or the TRP53 mutation hot spot in humans).